These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30349215)

  • 1. Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients.
    Zhang N; Gordon ML
    Clin Interv Aging; 2018; 13():1963-1970. PubMed ID: 30349215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.
    Jia J; Wei C; Chen W; Jia L; Zhou A; Wang F; Tang Y; Xu L
    J Alzheimers Dis; 2020; 74(1):199-211. PubMed ID: 31985467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.
    Jia J; Wei C; Jia L; Tang Y; Liang J; Zhou A; Li F; Shi L; Doody RS
    J Alzheimers Dis; 2017; 56(4):1495-1504. PubMed ID: 28157100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of memantine ER + donepezil for the treatment of Alzheimer's disease.
    Calhoun A; King C; Khoury R; Grossberg GT
    Expert Opin Pharmacother; 2018 Oct; 19(15):1711-1717. PubMed ID: 30244611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP2D6 and CYP3A4 genetic polymorphism on combined cholinesterase inhibitors and memantine treatment in mild to moderate Alzheimer's disease.
    Sonali N; Tripathi M; Sagar R; Velpandian T; Subbiah V
    Dement Geriatr Cogn Disord; 2014; 37(1-2):58-70. PubMed ID: 24107805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: Japan-Great Outcome of Long-term trial with Donepezil (J-GOLD).
    Arai H; Hashimoto N; Sumitomo K; Takase T; Ishii M
    Psychogeriatrics; 2018 Sep; 18(5):402-411. PubMed ID: 29993162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option.
    Yang H; Han W; Li H
    Pak J Pharm Sci; 2020 May; 33(3(Special)):1349-1354. PubMed ID: 33361021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
    Huisa BN; Thomas RG; Jin S; Oltersdorf T; Taylor C; Feldman HH
    J Alzheimers Dis; 2019; 67(2):707-713. PubMed ID: 30636733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial].
    Hu HT; Zhang ZX; Yao JL; Yu HZ; Wang YH; Tang HC; Ji CJ; Xu T
    Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):277-80. PubMed ID: 16780671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
    Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
    Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.
    Mohammad D; Chan P; Bradley J; Lanctôt K; Herrmann N
    Expert Opin Drug Saf; 2017 Sep; 16(9):1009-1019. PubMed ID: 28678552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M
    Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine.
    Wang HC; Liu NY; Zhang S; Yang Y; Wang ZY; Wei Y; Liu JG; Pei H; Li H
    Chin J Integr Med; 2020 Mar; 26(3):212-218. PubMed ID: 32180150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capabilities of combined therapy of Alzheimer's disease].
    Vasenina EE; Veryugina NI; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):45-50. PubMed ID: 36412156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of randomised controlled trials of physical activity in people with Alzheimer's disease and mild cognitive impairment with a comparison to donepezil.
    Pisani S; Mueller C; Huntley J; Aarsland D; Kempton MJ
    Int J Geriatr Psychiatry; 2021 Oct; 36(10):1471-1487. PubMed ID: 34490652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
    Rogers SL
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():29-42. PubMed ID: 9853200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.